Cardiac hormone replacement with BNP [nesiritide; Natrecor] in heart failure: a novel therapeutic strategy

Trial Profile

Cardiac hormone replacement with BNP [nesiritide; Natrecor] in heart failure: a novel therapeutic strategy

Completed
Phase of Trial: Phase I/II

Latest Information Update: 19 Dec 2012

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Acronyms SubqBNP
  • Most Recent Events

    • 19 Dec 2012 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 25 May 2012 Actual end date changed from 1 Jul 2008 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 25 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top